https://www.biospace.com/zymeworks-files-preliminary-prospectus-supplements-for-offering-of-common-shares-and-pre-funded-warrants
Zymeworks Inc. has filed a preliminary prospectus supplement to its Canadian short form base shelf prospectus dated March 6, 2019 in connection with an...
common shareszymeworksfilespreliminaryprospectus
https://www.businesswire.com/news/home/20200302005811/en/Zymeworks-Reports-2019-Year-End-Financial-Results
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the ...
year endzymeworksreportsfinancialresults